Spearheaded by his direct representation of global pharmaceutical and biotechnological companies for almost 30 years (including commercial medicines, vaccine, and diagnostic devices), Dr. Mark Lawrence Johnson, head of MJ Lawrence Consulting, has earned significant recognition by the international medical countermeasures community (industry, governments, and institutions). His “hands on” experience spans across the business: from strategic planning, project management, commerical operations, marketing, sales, to government affairs.
Following traditional roles with leading pharmaceutical companies (Merck & Co, Eli Lilly, Astellas), Mark joined the biotechnology industry in 2007 to become one of the early pioneers in the European chemical, biological, radiological, and nuclear (CBRN) medical countermeasures market and especially policy and procurement development. Hence, he has accrued a mature and extensive global network that expands throughout Europe, Asia, and the USA. Since 2011, he has had many of his articles published in renowned trade magazines and presses: CBRNe World, Cambridge University Press, Springer, Medical Corps International Forum (MCI Forum), and Security Europe TM (SecEUR Sprl).
Mark holds a BA in Business Management (University of Maryland), MBA (Wake Forest University), and a Doctorate in Economics (Université Paris-Panthéon-Assas) on a global public health policy topic: “International availability of medical countermeasures against chemical, biological, radiological, and nuclear agents”. While maintaining a US and European citizenship status, he is fluent in the English and German languages. In his free time, Mark is a jazz trumpet player and can be found playing live music in Munich, Germany.